Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

被引:61
作者
Criscuolo, Elena [1 ]
Caputo, V. [1 ,2 ]
Diotti, R. A. [1 ,2 ]
Sautto, G. A. [3 ]
Kirchenbaum, G. A. [4 ]
Clementi, N. [1 ]
机构
[1] Univ Vita Salute San Raffaele, Microbiol & Virol Unit, Milan, Italy
[2] Pomona Ric Srl, Turin, Italy
[3] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA
[4] Cellular Technol Ltd, Shaker Hts, OH USA
关键词
LACTIC-ACID BACTERIA; ORAL CHOLERA VACCINE; TOXIN-B-SUBUNIT; RECOMBINANT PROTEIN-PRODUCTION; SYSTEMIC IMMUNE-RESPONSES; INFLUENZA VACCINE; LACTOCOCCUS-LACTIS; SURFACE DISPLAY; GEM PARTICLES; MONOCLONAL-ANTIBODIES;
D O I
10.1155/2019/8303648
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccines are recognized worldwide as one of the most important tools for combating infectious diseases. Despite the tremendous value conferred by currently available vaccines toward public health, the implementation of additional vaccine platforms is also of key importance. In fact, currently available vaccines possess shortcomings, such as inefficient triggering of a cell-mediated immune response and the lack of protective mucosal immunity. In this regard, recent work has been focused on vaccine delivery systems, as an alternative to injectable vaccines, to increase antigen stability and improve overall immunogenicity. In particular, novel strategies based on edible or intradermal vaccine formulations have been demonstrated to trigger both a systemic and mucosal immune response. These novel vaccination delivery systems offer several advantages over the injectable preparations including self-administration, reduced cost, stability, and elimination of a cold chain. In this review, the latest findings and accomplishments regarding edible and intradermal vaccines are described in the context of the system used for immunogen expression, their molecular features and capacity to induce a protective systemic and mucosal response.
引用
收藏
页数:13
相关论文
共 148 条
[1]   Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures [J].
Akbari, Ali ;
Lavasanifar, Afsaneh ;
Wu, Jianping .
ACTA BIOMATERIALIA, 2017, 64 :249-258
[2]   Development of lactococcal GEM-based pneumococcal vaccines [J].
Audouy, Sandrine A. L. ;
van Selm, Saskia ;
van Roosmalen, Maarten L. ;
Post, Eduard ;
Kanninga, Rolf ;
Neef, Jolanda ;
Estevao, Silvia ;
Nieuwenhuis, Edward E. S. ;
Adrian, Peter V. ;
Leenhouts, Kees ;
Hermans, Peter W. M. .
VACCINE, 2007, 25 (13) :2497-2506
[3]   Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization [J].
Audouy, Sandrine A. L. ;
van Roosmalen, Maarten L. ;
Neef, Jolanda ;
Kanninga, Rolf ;
Post, Eduard ;
van Deemter, Marielle ;
Metselaar, Heidi ;
van Selm, Saskia ;
Robillard, George T. ;
Leenhouts, Kees J. ;
Hermans, Peter W. M. .
VACCINE, 2006, 24 (26) :5434-5441
[4]   Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania [J].
Bolhassani, Azam ;
Muller, Martin ;
Roohvand, Farzin ;
Motevalli, Fatemeh ;
Agi, Elnaz ;
Shokri, Mehdi ;
Rad, Mahdieh Motamedi ;
Hosseinzadeh, Sahar .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (12) :3499-3508
[5]   Novel surface display system for proteins on non-genetically modified gram-positive bacteria [J].
Bosma, T ;
Kanninga, R ;
Neef, J ;
Audouy, SAL ;
van Roosmalen, ML ;
Steen, A ;
Buist, G ;
Kok, J ;
Kuipers, OP ;
Robillard, G ;
Leenhouts, K .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2006, 72 (01) :880-889
[6]   Function of Mucosa-Associated Lymphoid Tissue in Antibody Formation [J].
Brandtzaeg, Per .
IMMUNOLOGICAL INVESTIGATIONS, 2010, 39 (4-5) :303-355
[7]   Intestinal Peyer's patch M cells and oral vaccine targeting [J].
Brayden, DJ ;
Jepson, MA ;
Baird, AW .
DRUG DISCOVERY TODAY, 2005, 10 (17) :1145-1157
[8]   The role of adjuvants in vaccines for seasonal and pandemic influenza [J].
Brown, Lorena E. .
VACCINE, 2010, 28 (50) :8043-8045
[9]   Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype [J].
Burioni, R ;
Matsuura, Y ;
Mancini, N ;
Tani, H ;
Miyamura, T ;
Varaldo, PE ;
Clementi, M .
JOURNAL OF VIROLOGY, 2002, 76 (22) :11775-11779
[10]   Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) [J].
Burioni, Roberto ;
Canducci, Filippo ;
Mancini, Nicasio ;
Clementi, Nicola ;
Sassi, Monica ;
De Marco, Donata ;
Diotti, Roberta Antonia ;
Saita, Diego ;
Sampaolo, Michela ;
Sautto, Giuseppe ;
Pianezze, Matteo ;
Clementi, Massimo .
VIROLOGY, 2010, 399 (01) :144-152